Preface

Frontiers in Clinical Drug Research - Anti-Cancer Agents presents recent developments of various therapeutic approaches against different types of cancer. The book is a valuable resource for pharmaceutical scientists, postgraduate students, and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research.

The five chapters in this volume are written by eminent authorities in the field. Chapter 1 presents the latest research progress in the use of essential oils and monoterpenes as anti-cancer agents. Chapter 2 gives an overview of current innovative approaches to glioblastoma, focusing on the therapeutic benefits of immunotherapeutic agents and drug delivery systems. Chapter 3 summarizes the roles of ctDNA in clinical practice for diagnosis, treatment choices and responses to therapy in various solid cancers. Chapter 4 focuses on the anti-cancer effects of pitavastatin, including its mechanism of action as well as the potential adverse reactions linked to its clinical use. Chapter 5 discusses the biphasic role of cholesterol, in and around the cancer tumor, as a model target for anti-cancer therapeutic management.

I hope that the readers will find these reviews valuable and thought-provoking so that they may trigger further research in the quest for new and novel therapies against cancers.

I am grateful for the timely efforts made by the editorial personnel, especially Mr. Mahmood Alam (Director Publications) and Mrs. Salma Sarfaraz (Senior Manager Publications) at Bentham Science Publishers.